サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1344446

コンシューマーヘルスケア市場：製品別、流通チャネル別：世界の機会分析と産業予測、2023-2032年

Consumer Healthcare Market By Product (OTC Pharmaceuticals, Personal Care Products, Dietary Supplements), By Distribution Channel (Online, Offline): Global Opportunity Analysis and Industry Forecast, 2023-2032
出版日: | 発行: Allied Market Research | ページ情報: 英文 270 Pages | 納期: 2～3営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=158.97円
コンシューマーヘルスケア市場：製品別、流通チャネル別：世界の機会分析と産業予測、2023-2032年
出版日: 2023年05月30日
発行: Allied Market Research
ページ情報: 英文 270 Pages
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

コンシューマーヘルスケア市場の2022年の市場規模は2,801億米ドルで、2032年には5,744億米ドルに達し、2023年から2032年までのCAGRは7.5%で成長すると予測されています。

Consumer Healthcare Market-IMG1

コンシューマーヘルスケア市場の成長は、スキンケア製品の需要の急増、ヘルスケア製品の自己購入傾向の増加、ヘルスケア関連書籍へのアクセスの増加によって促進されています。さらに、世界中のコンシューマーヘルスケア製品の大手企業が、最高のコンシューマーヘルスケア製品を提供する企業の買収にますます力を入れるようになっており、これが市場成長に顕著に寄与すると予想されます。例えば、2023年4月、大手一般用医薬品およびパーソナルケアブランドの開発・販売会社であるウェルスプリングコンシューマーヘルスケアは、認知度が高く信頼性の高い一般用医薬品（OTC）スキンケアブランドのポートフォリオであるアイコニックOTCスキンケアをバイエルAGから買収したことを発表しました。

さらに、世界のコンシューマーヘルスケア市場の成長は、パンデミック後の人々が身体の健康を維持するためにビタミンやミネラルの需要が大幅に増加していること、製造企業がコンシューマーヘルスケア製品の販売促進に向けて様々な取り組みを行っていること、オンライン製品を購入する傾向が強まっていることなどの要因によって大きく左右されます。世界のコンシューマーヘルスケア市場の有力企業は、市場での地位を強化し、競合環境を維持するために、製品の発売、買収、消費者向けにカスタマイズされたヘルスケア製品の開発のための研究開発への投資など、さまざまな戦略を選択しています。

世界中で感染症や皮膚病の憂慮すべき流行が増加していることは、市場の成長を促す主な要因の一つです。しかし、政府の厳しい規制やコンシューマーヘルスケア製品の誤用が市場の成長を制限しています。逆に、栄養補助食品に対する需要の増加や、特に新興国の患者における個人の健康に対する意識の高まりは、近い将来の市場成長に有利な機会をもたらすと予想されます。コンシューマーヘルスケア分野における広範な研究開発活動は、ヘルスケア・インフラの大幅な改善とともに、市場拡大の新たな道を開くと予想されます。

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 市場概要

  • 市場の定義と範囲
  • 主な調査結果
    • 影響要因
    • 主な投資機会
  • ポーターのファイブフォース分析
    • 供給企業の交渉力
    • 買い手の交渉力
    • 代替品の脅威
    • 新規参入業者の脅威
    • 競合の激しさ
  • 市場力学
    • 促進要因
      • 消費者の健康管理志向の高まり
      • ヘルスケアビジネスのデジタル化
      • パーソナルヘルスケアに対する意識の高まりと高齢人口の増加
    • 抑制要因
      • 政府の厳しい規制
    • 機会
      • コンシューマーヘルスケア市場における最新のスタートアップとカスタマイズ製品の開発
  • COVID-19市場への影響分析
  • 平均販売価格

第4章 コンシューマーヘルスケア市場：製品別

  • 概要
  • 一般用医薬品
  • パーソナルケア製品
  • 栄養補助食品

第5章 コンシューマーヘルスケア市場：流通チャネル別

  • 概要
  • オンライン
  • オフライン

第6章 コンシューマーヘルスケア市場：地域別

  • 概要
  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • ドイツ
    • フランス
    • 英国
    • イタリア
    • スペイン
    • その他欧州
  • アジア太平洋
    • 中国
    • 日本
    • インド
    • オーストラリア
    • 韓国
    • その他アジア太平洋地域
  • ラテンアメリカ・中東・アフリカ
    • ブラジル
    • サウジアラビア
    • 南アフリカ
    • その他の地域

第7章 競合情勢

  • イントロダクション
  • 主要成功戦略
  • 主要10社の製品マッピング
  • 競合ダッシュボード
  • 競合ヒートマップ
  • 主要企業のポジショニング、2022年

第8章 企業プロファイル

  • Johnson & Johnson
  • Sanofi S.A.
  • Pfizer Inc.
  • Abbott Laboratories
  • GlaxoSmithKline plc
  • BOEHRINGER INGELHEIM INTERNATIONAL GMBH
  • Teva Pharmaceutical Industries Limited
  • Amway Corp.
  • Bayer AG
  • BASF SE
図表

LIST OF TABLES

  • TABLE 01. GLOBAL CONSUMER HEALTHCARE MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 02. CONSUMER HEALTHCARE MARKET FOR OTC PHARMACEUTICALS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 03. CONSUMER HEALTHCARE MARKET FOR PERSONAL CARE PRODUCTS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 04. CONSUMER HEALTHCARE MARKET FOR DIETARY SUPPLEMENTS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 05. GLOBAL CONSUMER HEALTHCARE MARKET, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
  • TABLE 06. CONSUMER HEALTHCARE MARKET FOR ONLINE, BY REGION, 2022-2032 ($MILLION)
  • TABLE 07. CONSUMER HEALTHCARE MARKET FOR OFFLINE, BY REGION, 2022-2032 ($MILLION)
  • TABLE 08. GLOBAL OFFLINE CONSUMER HEALTHCARE MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 09. CONSUMER HEALTHCARE MARKET, BY REGION, 2022-2032 ($MILLION)
  • TABLE 10. NORTH AMERICA CONSUMER HEALTHCARE MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 11. NORTH AMERICA CONSUMER HEALTHCARE MARKET, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
  • TABLE 12. NORTH AMERICA CONSUMER HEALTHCARE MARKET, BY COUNTRY, 2022-2032 ($MILLION)
  • TABLE 13. U.S. CONSUMER HEALTHCARE MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 14. U.S. CONSUMER HEALTHCARE MARKET, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
  • TABLE 15. CANADA CONSUMER HEALTHCARE MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 16. CANADA CONSUMER HEALTHCARE MARKET, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
  • TABLE 17. MEXICO CONSUMER HEALTHCARE MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 18. MEXICO CONSUMER HEALTHCARE MARKET, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
  • TABLE 19. EUROPE CONSUMER HEALTHCARE MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 20. EUROPE CONSUMER HEALTHCARE MARKET, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
  • TABLE 21. EUROPE CONSUMER HEALTHCARE MARKET, BY COUNTRY, 2022-2032 ($MILLION)
  • TABLE 22. GERMANY CONSUMER HEALTHCARE MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 23. GERMANY CONSUMER HEALTHCARE MARKET, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
  • TABLE 24. FRANCE CONSUMER HEALTHCARE MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 25. FRANCE CONSUMER HEALTHCARE MARKET, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
  • TABLE 26. UK CONSUMER HEALTHCARE MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 27. UK CONSUMER HEALTHCARE MARKET, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
  • TABLE 28. ITALY CONSUMER HEALTHCARE MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 29. ITALY CONSUMER HEALTHCARE MARKET, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
  • TABLE 30. SPAIN CONSUMER HEALTHCARE MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 31. SPAIN CONSUMER HEALTHCARE MARKET, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
  • TABLE 32. REST OF EUROPE CONSUMER HEALTHCARE MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 33. REST OF EUROPE CONSUMER HEALTHCARE MARKET, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
  • TABLE 34. ASIA-PACIFIC CONSUMER HEALTHCARE MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 35. ASIA-PACIFIC CONSUMER HEALTHCARE MARKET, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
  • TABLE 36. ASIA-PACIFIC CONSUMER HEALTHCARE MARKET, BY COUNTRY, 2022-2032 ($MILLION)
  • TABLE 37. CHINA CONSUMER HEALTHCARE MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 38. CHINA CONSUMER HEALTHCARE MARKET, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
  • TABLE 39. JAPAN CONSUMER HEALTHCARE MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 40. JAPAN CONSUMER HEALTHCARE MARKET, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
  • TABLE 41. INDIA CONSUMER HEALTHCARE MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 42. INDIA CONSUMER HEALTHCARE MARKET, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
  • TABLE 43. AUSTRALIA CONSUMER HEALTHCARE MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 44. AUSTRALIA CONSUMER HEALTHCARE MARKET, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
  • TABLE 45. SOUTH KOREA CONSUMER HEALTHCARE MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 46. SOUTH KOREA CONSUMER HEALTHCARE MARKET, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
  • TABLE 47. REST OF ASIA-PACIFIC CONSUMER HEALTHCARE MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 48. REST OF ASIA-PACIFIC CONSUMER HEALTHCARE MARKET, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
  • TABLE 49. LAMEA CONSUMER HEALTHCARE MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 50. LAMEA CONSUMER HEALTHCARE MARKET, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
  • TABLE 51. LAMEA CONSUMER HEALTHCARE MARKET, BY COUNTRY, 2022-2032 ($MILLION)
  • TABLE 52. BRAZIL CONSUMER HEALTHCARE MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 53. BRAZIL CONSUMER HEALTHCARE MARKET, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
  • TABLE 54. SAUDI ARABIA CONSUMER HEALTHCARE MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 55. SAUDI ARABIA CONSUMER HEALTHCARE MARKET, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
  • TABLE 56. SOUTH AFRICA CONSUMER HEALTHCARE MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 57. SOUTH AFRICA CONSUMER HEALTHCARE MARKET, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
  • TABLE 58. REST OF LAMEA CONSUMER HEALTHCARE MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 59. REST OF LAMEA CONSUMER HEALTHCARE MARKET, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
  • TABLE 60. JOHNSON & JOHNSON: KEY EXECUTIVES
  • TABLE 61. JOHNSON & JOHNSON: COMPANY SNAPSHOT
  • TABLE 62. JOHNSON & JOHNSON: PRODUCT SEGMENTS
  • TABLE 63. JOHNSON & JOHNSON: PRODUCT PORTFOLIO
  • TABLE 64. JOHNSON & JOHNSON: KEY STRATERGIES
  • TABLE 65. SANOFI S.A.: KEY EXECUTIVES
  • TABLE 66. SANOFI S.A.: COMPANY SNAPSHOT
  • TABLE 67. SANOFI S.A.: PRODUCT SEGMENTS
  • TABLE 68. SANOFI S.A.: PRODUCT PORTFOLIO
  • TABLE 69. PFIZER INC.: KEY EXECUTIVES
  • TABLE 70. PFIZER INC.: COMPANY SNAPSHOT
  • TABLE 71. PFIZER INC.: PRODUCT SEGMENTS
  • TABLE 72. PFIZER INC.: PRODUCT PORTFOLIO
  • TABLE 73. ABBOTT LABORATORIES: KEY EXECUTIVES
  • TABLE 74. ABBOTT LABORATORIES: COMPANY SNAPSHOT
  • TABLE 75. ABBOTT LABORATORIES: PRODUCT SEGMENTS
  • TABLE 76. ABBOTT LABORATORIES: PRODUCT PORTFOLIO
  • TABLE 77. GLAXOSMITHKLINE PLC: KEY EXECUTIVES
  • TABLE 78. GLAXOSMITHKLINE PLC: COMPANY SNAPSHOT
  • TABLE 79. GLAXOSMITHKLINE PLC: PRODUCT SEGMENTS
  • TABLE 80. GLAXOSMITHKLINE PLC: PRODUCT PORTFOLIO
  • TABLE 81. GLAXOSMITHKLINE PLC: KEY STRATERGIES
  • TABLE 82. BOEHRINGER INGELHEIM INTERNATIONAL GMBH: KEY EXECUTIVES
  • TABLE 83. BOEHRINGER INGELHEIM INTERNATIONAL GMBH: COMPANY SNAPSHOT
  • TABLE 84. BOEHRINGER INGELHEIM INTERNATIONAL GMBH: PRODUCT SEGMENTS
  • TABLE 85. BOEHRINGER INGELHEIM INTERNATIONAL GMBH: PRODUCT PORTFOLIO
  • TABLE 86. TEVA PHARMACEUTICAL INDUSTRIES LIMITED: KEY EXECUTIVES
  • TABLE 87. TEVA PHARMACEUTICAL INDUSTRIES LIMITED: COMPANY SNAPSHOT
  • TABLE 88. TEVA PHARMACEUTICAL INDUSTRIES LIMITED: PRODUCT SEGMENTS
  • TABLE 89. TEVA PHARMACEUTICAL INDUSTRIES LIMITED: PRODUCT PORTFOLIO
  • TABLE 90. AMWAY CORP.: KEY EXECUTIVES
  • TABLE 91. AMWAY CORP.: COMPANY SNAPSHOT
  • TABLE 92. AMWAY CORP.: PRODUCT SEGMENTS
  • TABLE 93. AMWAY CORP.: PRODUCT PORTFOLIO
  • TABLE 94. BAYER AG: KEY EXECUTIVES
  • TABLE 95. BAYER AG: COMPANY SNAPSHOT
  • TABLE 96. BAYER AG: PRODUCT SEGMENTS
  • TABLE 97. BAYER AG: PRODUCT PORTFOLIO
  • TABLE 98. BASF SE: KEY EXECUTIVES
  • TABLE 99. BASF SE: COMPANY SNAPSHOT
  • TABLE 100. BASF SE: PRODUCT SEGMENTS
  • TABLE 101. BASF SE: PRODUCT PORTFOLIO

LIST OF FIGURES

  • FIGURE 01. CONSUMER HEALTHCARE MARKET, 2022-2032
  • FIGURE 02. SEGMENTATION OF CONSUMER HEALTHCARE MARKET, 2022-2032
  • FIGURE 03. TOP INVESTMENT POCKETS IN CONSUMER HEALTHCARE MARKET (2023-2032)
  • FIGURE 04. MODERATE BARGAINING POWER OF SUPPLIERS
  • FIGURE 05. MODERATE BARGAINING POWER OF BUYERS
  • FIGURE 06. MODERATE THREAT OF SUBSTITUTES
  • FIGURE 07. MODERATE THREAT OF NEW ENTRANTS
  • FIGURE 08. MODERATE INTENSITY OF RIVALRY
  • FIGURE 09. DRIVERS, RESTRAINTS AND OPPORTUNITIES: GLOBALCONSUMER HEALTHCARE MARKET
  • FIGURE 10. CONSUMER HEALTHCARE MARKET, BY PRODUCT, 2022(%)
  • FIGURE 11. COMPARATIVE SHARE ANALYSIS OF CONSUMER HEALTHCARE MARKET FOR OTC PHARMACEUTICALS, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 12. COMPARATIVE SHARE ANALYSIS OF CONSUMER HEALTHCARE MARKET FOR PERSONAL CARE PRODUCTS, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 13. COMPARATIVE SHARE ANALYSIS OF CONSUMER HEALTHCARE MARKET FOR DIETARY SUPPLEMENTS, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 14. CONSUMER HEALTHCARE MARKET, BY DISTRIBUTION CHANNEL, 2022(%)
  • FIGURE 15. COMPARATIVE SHARE ANALYSIS OF CONSUMER HEALTHCARE MARKET FOR ONLINE, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 16. COMPARATIVE SHARE ANALYSIS OF CONSUMER HEALTHCARE MARKET FOR OFFLINE, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 17. CONSUMER HEALTHCARE MARKET BY REGION, 2022
  • FIGURE 18. U.S. CONSUMER HEALTHCARE MARKET, 2022-2032 ($MILLION)
  • FIGURE 19. CANADA CONSUMER HEALTHCARE MARKET, 2022-2032 ($MILLION)
  • FIGURE 20. MEXICO CONSUMER HEALTHCARE MARKET, 2022-2032 ($MILLION)
  • FIGURE 21. GERMANY CONSUMER HEALTHCARE MARKET, 2022-2032 ($MILLION)
  • FIGURE 22. FRANCE CONSUMER HEALTHCARE MARKET, 2022-2032 ($MILLION)
  • FIGURE 23. UK CONSUMER HEALTHCARE MARKET, 2022-2032 ($MILLION)
  • FIGURE 24. ITALY CONSUMER HEALTHCARE MARKET, 2022-2032 ($MILLION)
  • FIGURE 25. SPAIN CONSUMER HEALTHCARE MARKET, 2022-2032 ($MILLION)
  • FIGURE 26. REST OF EUROPE CONSUMER HEALTHCARE MARKET, 2022-2032 ($MILLION)
  • FIGURE 27. CHINA CONSUMER HEALTHCARE MARKET, 2022-2032 ($MILLION)
  • FIGURE 28. JAPAN CONSUMER HEALTHCARE MARKET, 2022-2032 ($MILLION)
  • FIGURE 29. INDIA CONSUMER HEALTHCARE MARKET, 2022-2032 ($MILLION)
  • FIGURE 30. AUSTRALIA CONSUMER HEALTHCARE MARKET, 2022-2032 ($MILLION)
  • FIGURE 31. SOUTH KOREA CONSUMER HEALTHCARE MARKET, 2022-2032 ($MILLION)
  • FIGURE 32. REST OF ASIA-PACIFIC CONSUMER HEALTHCARE MARKET, 2022-2032 ($MILLION)
  • FIGURE 33. BRAZIL CONSUMER HEALTHCARE MARKET, 2022-2032 ($MILLION)
  • FIGURE 34. SAUDI ARABIA CONSUMER HEALTHCARE MARKET, 2022-2032 ($MILLION)
  • FIGURE 35. SOUTH AFRICA CONSUMER HEALTHCARE MARKET, 2022-2032 ($MILLION)
  • FIGURE 36. REST OF LAMEA CONSUMER HEALTHCARE MARKET, 2022-2032 ($MILLION)
  • FIGURE 37. TOP WINNING STRATEGIES, BY YEAR
  • FIGURE 38. TOP WINNING STRATEGIES, BY DEVELOPMENT
  • FIGURE 39. TOP WINNING STRATEGIES, BY COMPANY
  • FIGURE 40. PRODUCT MAPPING OF TOP 10 PLAYERS
  • FIGURE 41. COMPETITIVE DASHBOARD
  • FIGURE 42. COMPETITIVE HEATMAP: CONSUMER HEALTHCARE MARKET
  • FIGURE 43. TOP PLAYER POSITIONING, 2022
  • FIGURE 44. JOHNSON & JOHNSON: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 45. JOHNSON & JOHNSON: REVENUE SHARE BY SEGMENT, 2022 (%)
  • FIGURE 46. JOHNSON & JOHNSON: REVENUE SHARE BY REGION, 2022 (%)
  • FIGURE 47. SANOFI S.A.: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 48. SANOFI S.A.: REVENUE SHARE BY SEGMENT, 2022 (%)
  • FIGURE 49. SANOFI S.A.: REVENUE SHARE BY REGION, 2022 (%)
  • FIGURE 50. PFIZER INC.: NET REVENUE, 2020-2022 ($MILLION)
  • FIGURE 51. PFIZER INC.: REVENUE SHARE BY SEGMENT, 2022 (%)
  • FIGURE 52. PFIZER INC.: REVENUE SHARE BY REGION, 2022 (%)
  • FIGURE 53. ABBOTT LABORATORIES: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 54. ABBOTT LABORATORIES: RESEARCH & DEVELOPMENT EXPENDITURE, 2020-2022 ($MILLION)
  • FIGURE 55. ABBOTT LABORATORIES: REVENUE SHARE BY SEGMENT, 2021 (%)
  • FIGURE 56. ABBOTT LABORATORIES: REVENUE SHARE BY REGION, 2021 (%)
  • FIGURE 57. GLAXOSMITHKLINE PLC: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 58. GLAXOSMITHKLINE PLC: REVENUE SHARE BY SEGMENT, 2022 (%)
  • FIGURE 59. GLAXOSMITHKLINE PLC: REVENUE SHARE BY REGION, 2022 (%)
  • FIGURE 60. TEVA PHARMACEUTICAL INDUSTRIES LIMITED: NET REVENUE, 2020-2022 ($MILLION)
  • FIGURE 61. TEVA PHARMACEUTICAL INDUSTRIES LIMITED: REVENUE SHARE BY SEGMENT, 2022 (%)
  • FIGURE 62. BAYER AG: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 63. BAYER AG: RESEARCH & DEVELOPMENT EXPENDITURE, 2020-2022 ($MILLION)
  • FIGURE 64. BAYER AG: REVENUE SHARE BY SEGMENT, 2022 (%)
  • FIGURE 65. BAYER AG: REVENUE SHARE BY REGION, 2022 (%)
  • FIGURE 66. BASF SE: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 67. BASF SE: RESEARCH & DEVELOPMENT EXPENDITURE, 2020-2022 ($MILLION)
  • FIGURE 68. BASF SE: REVENUE SHARE BY SEGMENT, 2022 (%)
  • FIGURE 69. BASF SE: REVENUE SHARE BY REGION, 2022 (%)
目次
Product Code: A03171

According to a new report published by Allied Market Research, titled, "Consumer Healthcare Market," The consumer healthcare market was valued at $280.1 billion in 2022, and is estimated to reach $574.4 billion by 2032, growing at a CAGR of 7.5% from 2023 to 2032.

Consumer Healthcare Market - IMG1

The growth of the consumer healthcare market is driven by surge in demand of skin care products, increase in trend of self-buying healthcare products, and rise in access to the healthcare literatures. Moreover, large consumer healthcare products firms all over the world increasingly focus on acquiring companies that provide best consumer healthcare products, which is expected to notably contribute toward the market growth. For instance, in April 2023, WellSpring Consumer Healthcare, a developer and marketer of leading over-the-counter and personal care brands, announced the acquisition of Iconic OTC Skin Care, a portfolio of well-recognized and trusted over-the-counter (OTC) skin care brands from Bayer AG.

Furthermore, the global consumer healthcare market growth is largely driven by factors such as significant rise in demand of vitamins and minerals by people in post pandemic situation to maintain their physical health, and various initiatives by manufacturing companies to promote their consumer healthcare products, and the increase in trend of buying online products. Prominent players in the global consumer healthcare market have opted various strategies such as product launches, acquisition, and investments in R&D for development of customized consumer centric healthcare products to strengthen their position in the market and sustain the competitive environment.

An alarming increase in prevalence of infectious diseases and skin diseases across the globe is one of the key factors that drive the growth of the market. However, the stringent government regulations and misuse of consumer healthcare products restrict the market growth. Conversely, the increase in demand for nutraceuticals and the awareness about personal health, especially among patients in emerging nations, are expected to provide lucrative opportunities for the growth of the market in the near future. Extensive R&D activities in the field of consumer healthcare along with significant improvement in healthcare infrastructure are anticipated to open new avenues for the expansion of the market.

The consumer healthcare market is segmented on the basis of product, distribution channel, and region. On the basis of product, the market is categorized into OTC pharmaceuticals, personal care products and dietary supplements. On the basis of distribution channel, the market is classified into online and offline. The offline segment is further classified into supermarkets and hypermarkets, pharmacies, and others. On the basis of region, the market is studied across North America (the U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and Rest of Europe), Asia-Pacific (Japan, China, Australia, India, South Korea, and Rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA).

Major companies profiled in the report include: Johnson & Johnson, Sanofi, Pfizer Inc., Abbott Laboratories, GlaxoSmithKline plc, Boehringer Ingelheim GmbH, Teva Pharmaceutical Industries Ltd., Bayer AG, Amway, and BASF SE.

Key Benefits For Stakeholders

  • This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the consumer healthcare market analysis from 2022 to 2032 to identify the prevailing consumer healthcare market opportunities.
  • The market research is offered along with information related to key drivers, restraints, and opportunities.
  • Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
  • In-depth analysis of the consumer healthcare market segmentation assists to determine the prevailing market opportunities.
  • Major countries in each region are mapped according to their revenue contribution to the global market.
  • Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
  • The report includes the analysis of the regional as well as global consumer healthcare market trends, key players, market segments, application areas, and market growth strategies.

Key Market Segments

By Product

  • OTC Pharmaceuticals
  • Personal Care Products
  • Dietary Supplements

By Distribution Channel

  • Online
  • Offline
    • Type
    • Supermarkets and Hypermarkets
    • Pharmacies
    • Others

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • Saudi Arabia
    • South Africa
    • Rest of LAMEA

Key Market Players:

    • GlaxoSmithKline plc
    • Sanofi S.A.
    • BASF SE
    • Johnson & Johnson
    • Pfizer Inc.
    • BOEHRINGER INGELHEIM INTERNATIONAL GMBH
    • Amway Corp.
    • Teva Pharmaceutical Industries Limited
    • Bayer AG
    • Abbott Laboratories

TABLE OF CONTENTS

CHAPTER 1: INTRODUCTION

  • 1.1. Report description
  • 1.2. Key market segments
  • 1.3. Key benefits to the stakeholders
  • 1.4. Research Methodology
    • 1.4.1. Primary research
    • 1.4.2. Secondary research
    • 1.4.3. Analyst tools and models

CHAPTER 2: EXECUTIVE SUMMARY

  • 2.1. CXO Perspective

CHAPTER 3: MARKET OVERVIEW

  • 3.1. Market definition and scope
  • 3.2. Key findings
    • 3.2.1. Top impacting factors
    • 3.2.2. Top investment pockets
  • 3.3. Porter's five forces analysis
    • 3.3.1. Bargaining power of suppliers
    • 3.3.2. Bargaining power of buyers
    • 3.3.3. Threat of substitutes
    • 3.3.4. Threat of new entrants
    • 3.3.5. Intensity of rivalry
  • 3.4. Market dynamics
    • 3.4.1. Drivers
      • 3.4.1.1. Increase in consumers' desire to control their health
      • 3.4.1.2. Digitization of consumer healthcare business
      • 3.4.1.3. Rise in awareness about personal healthcare and increase in geriatric population
    • 3.4.2. Restraints
      • 3.4.2.1. The stringent government regulations
    • 3.4.3. Opportunities
      • 3.4.3.1. Latest startups in consumer healthcare market and development of customized products
  • 3.5. COVID-19 Impact Analysis on the market
  • 3.6. Average Selling Price

CHAPTER 4: CONSUMER HEALTHCARE MARKET, BY PRODUCT

  • 4.1. Overview
    • 4.1.1. Market size and forecast
  • 4.2. OTC Pharmaceuticals
    • 4.2.1. Key market trends, growth factors and opportunities
    • 4.2.2. Market size and forecast, by region
    • 4.2.3. Market share analysis by country
  • 4.3. Personal Care Products
    • 4.3.1. Key market trends, growth factors and opportunities
    • 4.3.2. Market size and forecast, by region
    • 4.3.3. Market share analysis by country
  • 4.4. Dietary Supplements
    • 4.4.1. Key market trends, growth factors and opportunities
    • 4.4.2. Market size and forecast, by region
    • 4.4.3. Market share analysis by country

CHAPTER 5: CONSUMER HEALTHCARE MARKET, BY DISTRIBUTION CHANNEL

  • 5.1. Overview
    • 5.1.1. Market size and forecast
  • 5.2. Online
    • 5.2.1. Key market trends, growth factors and opportunities
    • 5.2.2. Market size and forecast, by region
    • 5.2.3. Market share analysis by country
  • 5.3. Offline
    • 5.3.1. Key market trends, growth factors and opportunities
    • 5.3.2. Market size and forecast, by region
    • 5.3.3. Market share analysis by country
    • 5.3.4. Offline Consumer Healthcare Market by Type

CHAPTER 6: CONSUMER HEALTHCARE MARKET, BY REGION

  • 6.1. Overview
    • 6.1.1. Market size and forecast By Region
  • 6.2. North America
    • 6.2.1. Key trends and opportunities
    • 6.2.2. Market size and forecast, by Product
    • 6.2.3. Market size and forecast, by Distribution Channel
    • 6.2.4. Market size and forecast, by country
      • 6.2.4.1. U.S.
      • 6.2.4.1.1. Key market trends, growth factors and opportunities
      • 6.2.4.1.2. Market size and forecast, by Product
      • 6.2.4.1.3. Market size and forecast, by Distribution Channel
      • 6.2.4.2. Canada
      • 6.2.4.2.1. Key market trends, growth factors and opportunities
      • 6.2.4.2.2. Market size and forecast, by Product
      • 6.2.4.2.3. Market size and forecast, by Distribution Channel
      • 6.2.4.3. Mexico
      • 6.2.4.3.1. Key market trends, growth factors and opportunities
      • 6.2.4.3.2. Market size and forecast, by Product
      • 6.2.4.3.3. Market size and forecast, by Distribution Channel
  • 6.3. Europe
    • 6.3.1. Key trends and opportunities
    • 6.3.2. Market size and forecast, by Product
    • 6.3.3. Market size and forecast, by Distribution Channel
    • 6.3.4. Market size and forecast, by country
      • 6.3.4.1. Germany
      • 6.3.4.1.1. Key market trends, growth factors and opportunities
      • 6.3.4.1.2. Market size and forecast, by Product
      • 6.3.4.1.3. Market size and forecast, by Distribution Channel
      • 6.3.4.2. France
      • 6.3.4.2.1. Key market trends, growth factors and opportunities
      • 6.3.4.2.2. Market size and forecast, by Product
      • 6.3.4.2.3. Market size and forecast, by Distribution Channel
      • 6.3.4.3. UK
      • 6.3.4.3.1. Key market trends, growth factors and opportunities
      • 6.3.4.3.2. Market size and forecast, by Product
      • 6.3.4.3.3. Market size and forecast, by Distribution Channel
      • 6.3.4.4. Italy
      • 6.3.4.4.1. Key market trends, growth factors and opportunities
      • 6.3.4.4.2. Market size and forecast, by Product
      • 6.3.4.4.3. Market size and forecast, by Distribution Channel
      • 6.3.4.5. Spain
      • 6.3.4.5.1. Key market trends, growth factors and opportunities
      • 6.3.4.5.2. Market size and forecast, by Product
      • 6.3.4.5.3. Market size and forecast, by Distribution Channel
      • 6.3.4.6. Rest of Europe
      • 6.3.4.6.1. Key market trends, growth factors and opportunities
      • 6.3.4.6.2. Market size and forecast, by Product
      • 6.3.4.6.3. Market size and forecast, by Distribution Channel
  • 6.4. Asia-Pacific
    • 6.4.1. Key trends and opportunities
    • 6.4.2. Market size and forecast, by Product
    • 6.4.3. Market size and forecast, by Distribution Channel
    • 6.4.4. Market size and forecast, by country
      • 6.4.4.1. China
      • 6.4.4.1.1. Key market trends, growth factors and opportunities
      • 6.4.4.1.2. Market size and forecast, by Product
      • 6.4.4.1.3. Market size and forecast, by Distribution Channel
      • 6.4.4.2. Japan
      • 6.4.4.2.1. Key market trends, growth factors and opportunities
      • 6.4.4.2.2. Market size and forecast, by Product
      • 6.4.4.2.3. Market size and forecast, by Distribution Channel
      • 6.4.4.3. India
      • 6.4.4.3.1. Key market trends, growth factors and opportunities
      • 6.4.4.3.2. Market size and forecast, by Product
      • 6.4.4.3.3. Market size and forecast, by Distribution Channel
      • 6.4.4.4. Australia
      • 6.4.4.4.1. Key market trends, growth factors and opportunities
      • 6.4.4.4.2. Market size and forecast, by Product
      • 6.4.4.4.3. Market size and forecast, by Distribution Channel
      • 6.4.4.5. South Korea
      • 6.4.4.5.1. Key market trends, growth factors and opportunities
      • 6.4.4.5.2. Market size and forecast, by Product
      • 6.4.4.5.3. Market size and forecast, by Distribution Channel
      • 6.4.4.6. Rest of Asia-Pacific
      • 6.4.4.6.1. Key market trends, growth factors and opportunities
      • 6.4.4.6.2. Market size and forecast, by Product
      • 6.4.4.6.3. Market size and forecast, by Distribution Channel
  • 6.5. LAMEA
    • 6.5.1. Key trends and opportunities
    • 6.5.2. Market size and forecast, by Product
    • 6.5.3. Market size and forecast, by Distribution Channel
    • 6.5.4. Market size and forecast, by country
      • 6.5.4.1. Brazil
      • 6.5.4.1.1. Key market trends, growth factors and opportunities
      • 6.5.4.1.2. Market size and forecast, by Product
      • 6.5.4.1.3. Market size and forecast, by Distribution Channel
      • 6.5.4.2. Saudi Arabia
      • 6.5.4.2.1. Key market trends, growth factors and opportunities
      • 6.5.4.2.2. Market size and forecast, by Product
      • 6.5.4.2.3. Market size and forecast, by Distribution Channel
      • 6.5.4.3. South Africa
      • 6.5.4.3.1. Key market trends, growth factors and opportunities
      • 6.5.4.3.2. Market size and forecast, by Product
      • 6.5.4.3.3. Market size and forecast, by Distribution Channel
      • 6.5.4.4. Rest of LAMEA
      • 6.5.4.4.1. Key market trends, growth factors and opportunities
      • 6.5.4.4.2. Market size and forecast, by Product
      • 6.5.4.4.3. Market size and forecast, by Distribution Channel

CHAPTER 7: COMPETITIVE LANDSCAPE

  • 7.1. Introduction
  • 7.2. Top winning strategies
  • 7.3. Product Mapping of Top 10 Player
  • 7.4. Competitive Dashboard
  • 7.5. Competitive Heatmap
  • 7.6. Top player positioning, 2022

CHAPTER 8: COMPANY PROFILES

  • 8.1. Johnson & Johnson
    • 8.1.1. Company overview
    • 8.1.2. Key Executives
    • 8.1.3. Company snapshot
    • 8.1.4. Operating business segments
    • 8.1.5. Product portfolio
    • 8.1.6. Business performance
    • 8.1.7. Key strategic moves and developments
  • 8.2. Sanofi S.A.
    • 8.2.1. Company overview
    • 8.2.2. Key Executives
    • 8.2.3. Company snapshot
    • 8.2.4. Operating business segments
    • 8.2.5. Product portfolio
    • 8.2.6. Business performance
  • 8.3. Pfizer Inc.
    • 8.3.1. Company overview
    • 8.3.2. Key Executives
    • 8.3.3. Company snapshot
    • 8.3.4. Operating business segments
    • 8.3.5. Product portfolio
    • 8.3.6. Business performance
  • 8.4. Abbott Laboratories
    • 8.4.1. Company overview
    • 8.4.2. Key Executives
    • 8.4.3. Company snapshot
    • 8.4.4. Operating business segments
    • 8.4.5. Product portfolio
    • 8.4.6. Business performance
  • 8.5. GlaxoSmithKline plc
    • 8.5.1. Company overview
    • 8.5.2. Key Executives
    • 8.5.3. Company snapshot
    • 8.5.4. Operating business segments
    • 8.5.5. Product portfolio
    • 8.5.6. Business performance
    • 8.5.7. Key strategic moves and developments
  • 8.6. BOEHRINGER INGELHEIM INTERNATIONAL GMBH
    • 8.6.1. Company overview
    • 8.6.2. Key Executives
    • 8.6.3. Company snapshot
    • 8.6.4. Operating business segments
    • 8.6.5. Product portfolio
  • 8.7. Teva Pharmaceutical Industries Limited
    • 8.7.1. Company overview
    • 8.7.2. Key Executives
    • 8.7.3. Company snapshot
    • 8.7.4. Operating business segments
    • 8.7.5. Product portfolio
    • 8.7.6. Business performance
  • 8.8. Amway Corp.
    • 8.8.1. Company overview
    • 8.8.2. Key Executives
    • 8.8.3. Company snapshot
    • 8.8.4. Operating business segments
    • 8.8.5. Product portfolio
  • 8.9. Bayer AG
    • 8.9.1. Company overview
    • 8.9.2. Key Executives
    • 8.9.3. Company snapshot
    • 8.9.4. Operating business segments
    • 8.9.5. Product portfolio
    • 8.9.6. Business performance
  • 8.10. BASF SE
    • 8.10.1. Company overview
    • 8.10.2. Key Executives
    • 8.10.3. Company snapshot
    • 8.10.4. Operating business segments
    • 8.10.5. Product portfolio
    • 8.10.6. Business performance